Volume 27, Number 8—August 2021
Dispatch
Autochthonous Cases of Tick-Borne Encephalitis, Belgium, 2020
Table
Case no. | Symptom onset date | Exposure |
Sample type, days after symptom onset | Flavivirus IFA |
PRNT90 titer | rRT-PCR | ||
---|---|---|---|---|---|---|---|---|
Likely site, postal code | Likely route, time | IgM† | IgG‡ | |||||
1 | Jun 5 | Oostkamp, 8020 | Tick bite, 2 wk before symptom onset |
Serum, 5 | TBEV+ | TBEV+ | 1:25 | ND |
CSF, 6 |
TBEV+ |
TBEV+ |
ND |
ND |
||||
2 | Jun 21 | Lille, 2275 | Tick bite, 2 wk before symptom onset |
CSF, 18 | TBEV+ | TBEV+ | ND | ND |
Serum, 20 |
TBEV+ |
TBEV+ |
1:60 |
ND |
||||
3 | Jul 20 | Wanze, 4520 | Multiple tick bites in the weeks before symptom onset | Serum, 2 | – | – | ND | + |
Serum, 18 | TBEV+ | TBEV+ | 1:194 | ND |
*CSF, cerebrospinal fluid; IFA, immunofluorescence assay; ND, not done; PRNT90, plaque reduction neutralization testing at 90% sensitivity; rRT-PCR, real-time reverse transcription PCR; TBEV, tick-borne encephalitis virus; +, positive; –, negative. †Only TBEV-positive on the flavivirus mosaic IFA. ‡Also positive signal for >1 other flavivirus on the mosaic IFA, including West Nile virus, Japanese encephalitis virus, yellow fever virus, and dengue virus serotypes 1–4.
Page created: June 09, 2021
Page updated: July 18, 2021
Page reviewed: July 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.